AccuLine

AccuLineAccuLine
AccuLine

AccuLine

Developing CORA, a smart exam for early detection of coronary artery disease.

DR 26Speed 852022Inactive11
Rate

About

AccuLine Medical is a digital healthcare company focused on saving lives through early disease detection. They are developing CORA, a smart, accurate, and user-friendly exam designed for the early detection of coronary artery disease.
Frequently asked

What does AccuLine do?

AccuLine Medical is a digital healthcare company focused on saving lives through early disease detection. They are developing CORA, a smart, accurate, and user-friendly exam designed for the early detection of coronary artery disease.

What is AccuLine's revenue?

StartupHub estimates AccuLine's annual revenue at $2.0M (range $1.6M to $4.1M, 64% confidence), based on comparable companies in the sector.

What is AccuLine's valuation?

StartupHub estimates AccuLine's effective valuation at $22.4M (range $13.8M to $33.0M, 15% confidence), based on comparable companies in the sector.

How much funding has AccuLine raised?

AccuLine has raised a total of $6M in funding. The most recent round on record is Seed.

When was AccuLine founded?

AccuLine was founded in 2022.

What industry does AccuLine operate in?

AccuLine operates in Healthcare, Biomarkers, Heart, Coronary Artery Disease, Non-invasive, Cardiac.

How many employees does AccuLine have?

AccuLine has approximately 11 people on record.

What is AccuLine's current status?

AccuLine's current operating status is: Inactive.

HEADCOUNT
11
DOMAIN RATING
26
Comments

No comments yet. Be the first to share your take.